C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
Teva Pharmaceutical Industries continues to operate within a broad generic and specialty medicine landscape US market index ...
Merck & Company Inc (NYSE:MRK) has announced a major acquisition involving Terns Pharmaceuticals, marking an important ...
10d
Dame Doria Cordova Expands Money & You® to North America With New Course Offerings and Book Launch
The world’s longest-running entrepreneurial training program of 47 years brings expanded education to North America. For nearly five decades, we have watched entrepreneurs transform their businesses ...
A coalition of Indigenous leaders, farmers and rural Albertans is demanding there be a federal environmental review of Pathways, a planned carbon capture and storage facility and carbon dioxide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results